Press-release for stocks

| -69.16% | O: 2.8% H: 3.64% C: -1.82%
research conference therapeutics update

Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
LUCD | $0.7941 -0.61% -0.62% 120K

| -55.8% | O: 2.21% H: 4.32% C: 3.24%
ABT | News | $107.28 1.91% 0.18% 10M

| 1.52% | O: -0.14% H: 2.32% C: 2.16%
PAVM | $1.95 -1.03% 20K

| 217.69% | O: 4.82% H: 6.15% C: -4.08%
device diagnostic medical year diagnostics lucid-ms

Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
BXRX | $0.1864 -54.35% 330K

| -94.47% | O: 4.15% H: 22.51% C: 15.95%
bx1000 trial

EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE - December 8, 2022
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
EW | $85.94 -0.59% 0.0% 3.9M

| 20.22% | O: 1.47% H: 0.21% C: -1.59%
conference growth

KSQ Appoints Mahesh Karande to its Board of Directors
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
OMGA | $2.4 -0.83% -0.83% 400K

| -59.37% | O: 9.84% H: 7.08% C: -7.51%

EDWARDS LIFESCIENCES ANNOUNCES CEO SUCCESSION PLAN
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -18.19% | O: -0.2% H: 0.37% C: 0.21%
EW | $85.94 -0.59% 0.0% 3.9M

| 20.22% | O: 1.47% H: 0.21% C: -1.59%
ceo

LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

| -1.83% | O: 0.5% H: 0.16% C: 0.16%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -4.1% | O: -1.32% H: 0.0% C: 0.0%
fda designation drug candidate granted phase 2

EY announces alliance with EXL to support digital transformation initiatives in insurance, financial services and health care sectors
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
EXLS | $29.29 0.58% 0.58% 1.2M

| -83.31% | O: 0.82% H: 1.48% C: 0.78%
care services health financial

Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
DXCM | $130.71 -2.67% -2.75% 2.8M

| 15.78% | O: 4.91% H: 1.5% C: -0.83%
fda cleared system

Telecom Cloud Market worth $32.5 billion by 2027 - Exclusive Report by MarketsandMarkets™
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
NOKBF | News | $3.38 -2.55% 1.5K

| -28.91% | O: 3.85% H: 1.7% C: 1.48%
ORCL | $114.88 -0.97% 0.01% 8.2M

| 50.6% | O: 0.44% H: 1.36% C: 1.19%
NOK | News | $3.52 2.03% 0.0% 17M

| -30.19% | O: -0.62% H: 2.51% C: 2.3%
IBM | News | $181.58 0.06% -0.32% 3M

| 23.71% | O: 0.43% H: 0.85% C: -0.08%
BABA | $69.07 0.28% -0.07% 13M

Retail Trade

| -21.19% | O: 4.12% H: 2.57% C: 2.39%
MSFT | News F | $399.09 -1.28% -1.3% 29M

| 68.16% | O: 0.19% H: 1.59% C: 1.05%
ERIC | News | $5.1 0.79% 0.78% 19M

| -21.25% | O: 0.63% H: 1.26% C: 0.47%
DOX | $86.1 1.16% 1.15% 940K

| -3.89% | O: 0.0% H: 1.85% C: 0.71%
GOOGL | News S | $154.08 -1.24% -1.25% 32M

| 63.59% | O: 0.46% H: 0.21% C: -1.75%
GOOG | News S | $155.7 -1.12% -1.13% 20M

| 64.91% | O: 0.57% H: 0.19% C: -1.82%
report market cloud

'Tis the Season for Red Robin's New OREO® Peppermint Crunch Milkshake
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
RRGB | $6.42 7.0% 6.54% 270K

Consumer Services

| -17.13% | O: -0.14% H: 3.38% C: 2.09%
oreo

Precision Optics Announces New Product Development Order for Single Use Urology Program
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
PEYED | $6.2

n/a

| Email alert Add to watchlist
order program

Nucor Investing in Start-Up Company Developing Zero-Carbon Iron Technology
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
NUE | $191.36 0.31% 0.0% 1.6M

Non-Energy Minerals

| 29.05% | O: 2.04% H: 0.6% C: -1.31%
technology

Marvell Extends 5nm Data Infrastructure Leadership with Launch of Secure 1.6T Ethernet PHY for Cloud and 5G Markets
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
MRVL A | $62.13 -4.77% -5.01% 15M